zopiclone has been researched along with morphine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Conci, F; Ferrario, P; Hafner, B; Mantegazza, P; Tammiso, R; Zambotti, F; Zecca, L; Zonta, N | 1 |
| Chernes, Y; Pick, CG; Rice, KC; Rigai, T; Schreiber, S | 1 |
| Baranchuk, A; Gibson, K; Methot, M; Simpson, CS; Strum, D | 1 |
| Backman, E; Höjer, J; Jonsson, B; Salmonson, H | 1 |
| Johansen, SS; Linnet, K; Nielsen, MKK; Wang, X | 1 |
9 other study(ies) available for zopiclone and morphine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Zopiclone potentiates the antinociceptive effect of morphine in rats.
Topics: Animals; Azabicyclo Compounds; Benzodiazepines; Benzodiazepinones; Drug Synergism; Flumazenil; Hypnotics and Sedatives; Male; Morphine; Pain; Pain Measurement; Piperazines; Rats; Rats, Inbred Strains; Sensory Thresholds | 1987 |
The antinociceptive effect of zolpidem and zopiclone in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic Agonists; Adrenergic Antagonists; Analgesics; Animals; Azabicyclo Compounds; Behavior, Animal; Benzamides; Clonidine; Dose-Response Relationship, Drug; Hypnotics and Sedatives; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Narcotic Antagonists; Pain; Pain Measurement; Piperazines; Pyridines; Receptors, Opioid; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Zolpidem | 2005 |
Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines.
Topics: Antidepressive Agents, Second-Generation; Arrhythmias, Cardiac; Azabicyclo Compounds; Benzodiazepines; Citalopram; Depression; Drug Overdose; Electrocardiography; Heart Rate; Humans; Hypnotics and Sedatives; Male; Middle Aged; Morphine; Narcotics; Oxycodone; Piperazines; Sleep Initiation and Maintenance Disorders; Suicide, Attempted | 2008 |
Injection of crushed tablets--a prospective observational study.
Topics: Adolescent; Adult; Azabicyclo Compounds; Benzodiazepines; Buprenorphine; C-Reactive Protein; Female; gamma-Aminobutyric Acid; Humans; Injections, Intravenous; Male; Methylphenidate; Morphine; Oxycodone; Piperazines; Poison Control Centers; Pregabalin; Prospective Studies; Substance-Related Disorders; Sweden; Tablets; Young Adult | 2014 |
Segmental Hair Analysis-Interpretation of the Time of Drug Intake in Two Patients Undergoing Drug Treatment.
Topics: Acetaminophen; Adult; Analgesics; Antiemetics; Azabicyclo Compounds; Citalopram; Female; Forensic Toxicology; Hair; Humans; Hypnotics and Sedatives; Metoclopramide; Morphine; Oxazepam; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sumatriptan; Tramadol; Vasoconstrictor Agents | 2019 |